See more of what matters with the INFORM HER2 Dual ISH DNA Probe Cocktail assay

Bring the power of brightfield ISH testing to your lab


Use all we’ve learned about automated in situ testing to benefit your practice and the patients who count on your work

  • Results are easily scored using brightfield microscopy — in-house with familiar technologies
  • HER2 gene amplification assessment over the entire slide — not just a pre-selected area — facilitates scoring and identification of heterogeneity
  • Simultaneous morphological assessment independent of H&E stain
  • Archivable results allow for easy maintenance and simplifies consults in difficult cases
  • Enhanced technical support tools — including clear, consolidated guidance on best practices and streamlined training

Let’s build confidence together


 > Visit product catalog

Publications assessing INFORM HER2 Dual ISH DNA Probe Cocktail

Testing HER2 in Breast Cancer-A Comparative Study on BRISH, FISH, and IHC
View on PubMed

Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer
View on PubMed

Comparison of Dual-ISH (DISH) With Fluorescence In Situ Hybridization (FISH) and Correlation With
Immunohistochemical Findings for HER2/Neu Status in Breast Carcinoma
View on PubMed

Real patient stories

We’ve told you how we do it. Now we’ll show you why.

> Real patient stories

 Breast cancer disease state

15-20% of breast cancer patients overexpress the HER2 protein & are eligible for treatment with highly effective HER2-targeted personalized therapies that improve outcomes.

> Learn more